Guimarães, T.; Borges, I.C.; Spadão, F.d.S.; Mariano, L.; Nascimento, M.d.M.; Higashino, H.; Rossi, F.; Rocha, V.; Costa, S.F.
Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients. Antibiotics 2022, 11, 1269.
https://doi.org/10.3390/antibiotics11091269
AMA Style
Guimarães T, Borges IC, Spadão FdS, Mariano L, Nascimento MdM, Higashino H, Rossi F, Rocha V, Costa SF.
Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients. Antibiotics. 2022; 11(9):1269.
https://doi.org/10.3390/antibiotics11091269
Chicago/Turabian Style
Guimarães, ThaÃs, Igor Carmo Borges, Fernanda de Souza Spadão, Livia Mariano, Marina de Mattos Nascimento, Hermes Higashino, Flavia Rossi, Vanderson Rocha, and Silvia Figueiredo Costa.
2022. "Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients" Antibiotics 11, no. 9: 1269.
https://doi.org/10.3390/antibiotics11091269
APA Style
Guimarães, T., Borges, I. C., Spadão, F. d. S., Mariano, L., Nascimento, M. d. M., Higashino, H., Rossi, F., Rocha, V., & Costa, S. F.
(2022). Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients. Antibiotics, 11(9), 1269.
https://doi.org/10.3390/antibiotics11091269
